EP0910569A4 - Extracellular/epidermal growth factor-like protein - Google Patents

Extracellular/epidermal growth factor-like protein

Info

Publication number
EP0910569A4
EP0910569A4 EP96912802A EP96912802A EP0910569A4 EP 0910569 A4 EP0910569 A4 EP 0910569A4 EP 96912802 A EP96912802 A EP 96912802A EP 96912802 A EP96912802 A EP 96912802A EP 0910569 A4 EP0910569 A4 EP 0910569A4
Authority
EP
European Patent Office
Prior art keywords
extracellular
protein
growth factor
epidermal growth
epidermal
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Withdrawn
Application number
EP96912802A
Other languages
German (de)
French (fr)
Other versions
EP0910569A1 (en
Inventor
Henrik S Olsen
Haodong Li
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Human Genome Sciences Inc
Original Assignee
Human Genome Sciences Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Human Genome Sciences Inc filed Critical Human Genome Sciences Inc
Publication of EP0910569A1 publication Critical patent/EP0910569A1/en
Publication of EP0910569A4 publication Critical patent/EP0910569A4/en
Withdrawn legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/16—Drugs for disorders of the alimentary tract or the digestive system for liver or gallbladder disorders, e.g. hepatoprotective agents, cholagogues, litholytics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/12—Drugs for disorders of the urinary system of the kidneys
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/02—Drugs for dermatological disorders for treating wounds, ulcers, burns, scars, keloids, or the like
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/475—Growth factors; Growth regulators
    • C07K14/485—Epidermal growth factor [EGF], i.e. urogastrone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K48/00—Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2799/00—Uses of viruses
    • C12N2799/02—Uses of viruses as vector
    • C12N2799/021—Uses of viruses as vector for the expression of a heterologous nucleic acid
    • C12N2799/026—Uses of viruses as vector for the expression of a heterologous nucleic acid where the vector is derived from a baculovirus

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Animal Behavior & Ethology (AREA)
  • Engineering & Computer Science (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Dermatology (AREA)
  • Urology & Nephrology (AREA)
  • Zoology (AREA)
  • Toxicology (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Ophthalmology & Optometry (AREA)
  • Peptides Or Proteins (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
EP96912802A 1996-04-10 1996-04-10 Extracellular/epidermal growth factor-like protein Withdrawn EP0910569A4 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
CA002249213A CA2249213A1 (en) 1996-04-10 1996-04-10 Extracellular/epidermal growth factor-like protein
PCT/US1996/005247 WO1997038002A1 (en) 1996-04-10 1996-04-10 Extracellular/epidermal growth factor-like protein

Publications (2)

Publication Number Publication Date
EP0910569A1 EP0910569A1 (en) 1999-04-28
EP0910569A4 true EP0910569A4 (en) 2002-05-08

Family

ID=25680533

Family Applications (1)

Application Number Title Priority Date Filing Date
EP96912802A Withdrawn EP0910569A4 (en) 1996-04-10 1996-04-10 Extracellular/epidermal growth factor-like protein

Country Status (5)

Country Link
EP (1) EP0910569A4 (en)
JP (1) JP2000508531A (en)
AU (1) AU5549296A (en)
CA (1) CA2249213A1 (en)
WO (1) WO1997038002A1 (en)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2002511743A (en) * 1997-04-11 2002-04-16 ヒューマン ジノーム サイエンシーズ，インコーポレイテッド Extracellular / epidermal growth factor-like protein
US5872234A (en) * 1997-06-27 1999-02-16 Incyte Pharmaceuticals, Inc. Human extracellular matrix proteins
US6300311B1 (en) 1998-04-14 2001-10-09 Texas Tech University Regulation of vertebrate ovarian maturation and function using growth factors
EP1074622A4 (en) * 1998-04-28 2004-05-19 Ono Pharmaceutical Co NOVEL POLYPEPTIDE, cDNA ENCODING THE SAME AND UTILIZATION THEREOF
AUPP489798A0 (en) * 1998-07-28 1998-08-20 Mediko Pty Ltd Hair growth/maintenance compositions and methods

Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1985000369A1 (en) * 1983-07-05 1985-01-31 Chiron Corporation Hybrid dna synthesis of epidermal growth factor
DE3910084A1 (en) * 1988-03-24 1989-11-16 Oncogen POLYPEPTIDES WITH GROWTH FACTOR ACTIVITY AND NUCLEAR SEA SEQUENCES

Patent Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1985000369A1 (en) * 1983-07-05 1985-01-31 Chiron Corporation Hybrid dna synthesis of epidermal growth factor
DE3910084A1 (en) * 1988-03-24 1989-11-16 Oncogen POLYPEPTIDES WITH GROWTH FACTOR ACTIVITY AND NUCLEAR SEA SEQUENCES

Non-Patent Citations (5)

* Cited by examiner, † Cited by third party
Title
CHANDLER L P ET AL: "A MONOCLONAL ANTIBODY WHICH INHIBITS EPIDERMAL GROWTH FACTOR BINDING HAS OPPOSITE EFFECTS ON THE BIOLOGICAL ACTION OF EPIDERMAL GROWTH FACTOR IN DIFFERENT CELLS", JOURNAL OF BIOLOGICAL CHEMISTRY, vol. 260, no. 6, 1985, pages 3360 - 3367, XP001029556, ISSN: 0021-9258 *
DATABASE EMBL 30 January 1995 (1995-01-30), BOUILLAUD F.: "Study of expressed sequence tags in adipose tissue 1994", XP002181544 *
ECKERT K ET AL: "A 43000-MOLECULAR-WEIGHT EPIDERMAL GROWTH FACTOR-RELATED PROTEIN PURIFIED FROM THE URINE OF BREAST CANCER PATIENTS", CANCER RESEARCH, vol. 50, no. 3, 1990, pages 642 - 647, XP001018852, ISSN: 0008-5472 *
LECKA-CZERNIK B ET AL: "AN OVEREXPRESSED GENE TRANSCRIPT IN SENESCENT AND QUIESCENT HUMAN FIBROBLASTS ENCODING A NOVEL PROTEIN IN THE EPIDERMAL GROWTH FACTOR-LIKE REPEAT FAMILY STIMULATES DNA-SYNTHESIS", MOLECULAR AND CELLULAR BIOLOGY, WASHINGTON, DC, US, vol. 15, no. 1, 1995, pages 120 - 128, XP002036980, ISSN: 0270-7306 *
See also references of WO9738002A1 *

Also Published As

Publication number Publication date
CA2249213A1 (en) 1997-10-16
WO1997038002A1 (en) 1997-10-16
AU5549296A (en) 1997-10-29
EP0910569A1 (en) 1999-04-28
JP2000508531A (en) 2000-07-11

Similar Documents

Publication Publication Date Title
HUP0004611A3 (en) April- a novel protein with growth effects
AU2426497A (en) Synthetic peptide derivatives with nerve growth factor-like neurotrophic activity
AU5721798A (en) Human mage-like protein
EP0929575A4 (en) Novel human growth factors
EP0902791A4 (en) Extracellular/epidermal growth factor hcaba58x
EP0904292A4 (en) Growth differentiation factor-14
ZA975202B (en) Plants proteins
ZA9710338B (en) Proteins
AU4480697A (en) Human nm23-like protein
AU130272S (en) Ladies shaver
AU132697S (en) Edging scissors
EP0910569A4 (en) Extracellular/epidermal growth factor-like protein
AU4744997A (en) Novel human phospholemman-like protein
GB2305881A8 (en) Sliding knife pruner
AU2002300108A1 (en) Extracellular/Epidermal Growth Factor Like Protein
AU2854600A (en) Human polypeptide having multiple epidermal growth factor (egf) -like domains, zntr2
AU8377298A (en) New human growth regulator protein
AU5802798A (en) Human oncogene induced secreted protein i
EP1100523A4 (en) Treatment of central nervous system ischemia or trauma with epidermal growth factor-like polypeptides
GB9611893D0 (en) Powered branch lopper
EP0915100A4 (en) Novel protein
AU4425797A (en) Novel human interferon-inducible protein
EP0891372A4 (en) Growth factor htter36
GB9824045D0 (en) Regulator protein
IL117401A0 (en) Greenhouse

Legal Events

Date Code Title Description
PUAI Public reference made under article 153(3) epc to a published international application that has entered the european phase

Free format text: ORIGINAL CODE: 0009012

17P Request for examination filed

Effective date: 19981109

AK Designated contracting states

Kind code of ref document: A1

Designated state(s): AT BE CH DE DK ES FI FR GB GR IE IT LI LU MC NL PT SE

A4 Supplementary search report drawn up and despatched

Effective date: 20020321

AK Designated contracting states

Kind code of ref document: A4

Designated state(s): AT BE CH DE DK ES FI FR GB GR IE IT LI LU MC NL PT SE

17Q First examination report despatched

Effective date: 20030807

STAA Information on the status of an ep patent application or granted ep patent

Free format text: STATUS: THE APPLICATION HAS BEEN WITHDRAWN

18W Application withdrawn

Effective date: 20050124